Skip to main content
Jennifer Cheng

Jennifer Cheng, PhD

Co-founder & CEO, PTM Therapeutics, Inc.
United States
Jennifer C. Cheng, Ph.D., J.D. (CEO/Co-Founder): With over 20 years of experience, Dr. Cheng is a biotech industry veteran and has experience in a variety of roles in drug development. Most recently, Dr. Cheng has been the vice president of legal affairs and general counsel at Adverum Biotechnologies from 2015 to 2019. Previously, Dr. Cheng was patent counsel with Allergan, where she was responsible for developing and implementing patent strategy. She also served as the senior patent counsel for MAP Pharmaceuticals until it was acquired by Allergan in 2013. Previously, Dr. Cheng was the manager of intellectual property for Solazyme, Inc. and patent counsel at Raven Biotechnologies. Dr. Cheng began her career at Genentech as a research associate. She received a B.A. in Molecular and Cellular Biology and Rhetoric from the University of California, Berkeley. She earned a Ph.D. in tumor cell biology and molecular medicine from Northwestern University and a J.D. from Santa Clara University School of Law.

Double Helix


Supporting Bank Sponsor


Premier Sponsors

Conference Sponsors


Media Partner


Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.